Literature DB >> 16798248

Oklahoma prosthesis: resection of tumor of clavicle and chest wall reconstructed with a custom composite graft.

Shant M Vartanian1, Shanthi Colaco, Lisa E Orloff, Pierre R Theodore.   

Abstract

Tumors involving the clavicle by primary or metastatic growth may require clavicular resection often with rib resection. The resulting cosmetic and functional impairment of clavicular resection may be significant with a sloped appearing shoulder girdle and chronically impaired movement of the upper extremity. We report a 48-year-old woman presenting with a bulky metastatic renal cell mass of her left clavicle extending to the chest wall. We report en-bloc clavilculectomy and chest wall resection with a novel method of reconstruction using a single methyl methacrylate and prolene composite prosthesis in a configuration resembling the state of Oklahoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16798248     DOI: 10.1016/j.athoracsur.2005.09.029

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

Review 1.  Clavicular Malignancies: A Borderline Surgical Management.

Authors:  Claudiu-Eduard Nistor; Adrian Ciuche; Anca-Pati Cucu; Bogdan Serban; Adrian Cursaru; Bogdan Cretu; Catalin Cirstoiu
Journal:  Medicina (Kaunas)       Date:  2022-07-08       Impact factor: 2.948

2.  Outcome of bone defect reconstruction with clavicle bone cement prosthesis after tumor resection: a case series study.

Authors:  Bin Lin; Yong He; Yang Xu; Mo Sha
Journal:  BMC Musculoskelet Disord       Date:  2014-05-29       Impact factor: 2.362

3.  Pathological clavicular fracture as first presentation of renal cell carcinoma: a case report and literature review.

Authors:  Yan Kong; Jin Wang; Huan Li; Peng Guo; Jian-Fa Xu; He-Lin Feng
Journal:  Cancer Biol Med       Date:  2015-12       Impact factor: 4.248

Review 4.  Thoracic Wall Reconstruction after Tumor Resection.

Authors:  Kamran Harati; Jonas Kolbenschlag; Björn Behr; Ole Goertz; Tobias Hirsch; Nicolai Kapalschinski; Andrej Ring; Marcus Lehnhardt; Adrien Daigeler
Journal:  Front Oncol       Date:  2015-10-29       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.